550 related articles for article (PubMed ID: 30218190)
1. Long-term renal follow-up of children treated with cisplatin, carboplatin, or ifosfamide: a pilot study.
McMahon KR; Harel-Sterling M; Pizzi M; Huynh L; Hessey E; Zappitelli M
Pediatr Nephrol; 2018 Dec; 33(12):2311-2320. PubMed ID: 30218190
[TBL] [Abstract][Full Text] [Related]
2. Early and late renal adverse effects after potentially nephrotoxic treatment for childhood cancer.
Knijnenburg SL; Mulder RL; Schouten-Van Meeteren AY; Bökenkamp A; Blufpand H; van Dulmen-den Broeder E; Veening MA; Kremer LC; Jaspers MW
Cochrane Database Syst Rev; 2013 Oct; (10):CD008944. PubMed ID: 24101439
[TBL] [Abstract][Full Text] [Related]
3. Early and late adverse renal effects after potentially nephrotoxic treatment for childhood cancer.
Kooijmans EC; Bökenkamp A; Tjahjadi NS; Tettero JM; van Dulmen-den Broeder E; van der Pal HJ; Veening MA
Cochrane Database Syst Rev; 2019 Mar; 3(3):CD008944. PubMed ID: 30855726
[TBL] [Abstract][Full Text] [Related]
4. Urine biomarkers of acute kidney injury in noncritically ill, hospitalized children treated with chemotherapy.
Sterling M; Al-Ismaili Z; McMahon KR; Piccioni M; Pizzi M; Mottes T; Lands LC; Abish S; Fleming AJ; Bennett MR; Palijan A; Devarajan P; Goldstein SL; O'Brien MM; Zappitelli M
Pediatr Blood Cancer; 2017 Oct; 64(10):. PubMed ID: 28417544
[TBL] [Abstract][Full Text] [Related]
5. Acute kidney injury during cisplatin therapy and associations with kidney outcomes 2 to 6 months post-cisplatin in children: a multi-centre, prospective observational study.
McMahon KR; Lebel A; Rassekh SR; Schultz KR; Blydt-Hansen TD; Cuvelier GDE; Mammen C; Pinsk M; Carleton BC; Tsuyuki RT; Ross CJD; Huynh L; Yordanova M; Crépeau-Hubert F; Wang S; Palijan A; Lee J; Boyko D; Zappitelli M;
Pediatr Nephrol; 2023 May; 38(5):1667-1685. PubMed ID: 36260162
[TBL] [Abstract][Full Text] [Related]
6. The Dutch Childhood Cancer Survivor Study (DCCSS)-LATER 2 kidney analysis examined long-term glomerular dysfunction in childhood cancer survivors.
Kooijmans ECM; van der Pal HJH; Pluijm SMF; van der Heiden-van der Loo M; Kremer LCM; Bresters D; van Dulmen-den Broeder E; van den Heuvel-Eibrink MM; Loonen JJ; Louwerens M; Neggers SJC; Ronckers C; Tissing WJE; de Vries ACH; Kaspers GJL; Veening MA; Bökenkamp A;
Kidney Int; 2022 Nov; 102(5):1136-1146. PubMed ID: 35772499
[TBL] [Abstract][Full Text] [Related]
7. Acute Kidney Injury in Sugarcane Workers at Risk for Mesoamerican Nephropathy.
Kupferman J; Ramírez-Rubio O; Amador JJ; López-Pilarte D; Wilker EH; Laws RL; Sennett C; Robles NV; Lau JL; Salinas AJ; Kaufman JS; Weiner DE; Scammell MK; McClean MD; Brooks DR; Friedman DJ
Am J Kidney Dis; 2018 Oct; 72(4):475-482. PubMed ID: 30042041
[TBL] [Abstract][Full Text] [Related]
8. Incidence and risk factors for acute kidney injury in head and neck cancer patients treated with concurrent chemoradiation with high-dose cisplatin.
van der Vorst MJDL; Neefjes ECW; Toffoli EC; Oosterling-Jansen JEW; Vergeer MR; Leemans CR; Kooistra MP; Voortman J; Verheul HMW
BMC Cancer; 2019 Nov; 19(1):1066. PubMed ID: 31703649
[TBL] [Abstract][Full Text] [Related]
9. 24-Hour ambulatory blood pressure monitoring 7 years after intensive care unit admission.
Hessey E; Paun A; Benisty K; McMahon K; Palijan A; Pizzi M; Morgan C; Zappitelli M
Pediatr Nephrol; 2022 Aug; 37(8):1877-1887. PubMed ID: 35039930
[TBL] [Abstract][Full Text] [Related]
10. Comparative study of the acute nephrotoxicity from standard dose cisplatin +/- ifosfamide and high-dose chemotherapy with carboplatin and ifosfamide.
Hartmann JT; Fels LM; Franzke A; Knop S; Renn M; Maess B; Panagiotou P; Lampe H; Kanz L; Stolte H; Bokemeyer C
Anticancer Res; 2000; 20(5C):3767-73. PubMed ID: 11268452
[TBL] [Abstract][Full Text] [Related]
11. Comparison of three equations for estimating glomerular filtration rate as predictors of cisplatin-related acute kidney injury in lung cancer patients with normal renal function.
Karaboyun K; İriağaç Y; Çavdar E; Avci O; Şeber ES
J Cancer Res Ther; 2024 Jan; 20(1):144-149. PubMed ID: 38554312
[TBL] [Abstract][Full Text] [Related]
12. Impact of acute kidney injury defined by CTCAE v4.0 during first course of cisplatin-based chemotherapy on treatment outcomes in advanced urothelial cancer patients.
Ishitsuka R; Miyazaki J; Ichioka D; Inoue T; Kageyama S; Sugimoto M; Mitsuzuka K; Matsui Y; Shiraishi Y; Kinoshita H; Wakeda H; Nomoto T; Kikuchi E; Kawai K; Nishiyama H
Clin Exp Nephrol; 2017 Aug; 21(4):732-740. PubMed ID: 27565169
[TBL] [Abstract][Full Text] [Related]
13. Persistent nephrotoxicity during 10-year follow-up after cisplatin or carboplatin treatment in childhood: relevance of age and dose as risk factors.
Skinner R; Parry A; Price L; Cole M; Craft AW; Pearson AD
Eur J Cancer; 2009 Dec; 45(18):3213-9. PubMed ID: 19850470
[TBL] [Abstract][Full Text] [Related]
14. CKD and hypertension during long-term follow-up in children and adolescents previously treated with extracorporeal membrane oxygenation.
Zwiers AJ; IJsselstijn H; van Rosmalen J; Gischler SJ; de Wildt SN; Tibboel D; Cransberg K
Clin J Am Soc Nephrol; 2014 Dec; 9(12):2070-8. PubMed ID: 25278545
[TBL] [Abstract][Full Text] [Related]
15. Possible risk of overestimation of renal function using cystatin C-based eGFR in testicular cancer survivors treated with cisplatin-based chemotherapy.
Ichioka D; Kawai K; Tanaka K; Ishitsuka R; Yoshino T; Kimura T; Kandori S; Kawahara T; Kojima T; Usui J; Yamagata K; Miyazaki J; Nishiyama H
Clin Exp Nephrol; 2018 Jun; 22(3):727-734. PubMed ID: 28948387
[TBL] [Abstract][Full Text] [Related]
16. Epidemiologic Characteristics of Acute Kidney Injury During Cisplatin Infusions in Children Treated for Cancer.
McMahon KR; Rassekh SR; Schultz KR; Blydt-Hansen T; Cuvelier GDE; Mammen C; Pinsk M; Carleton BC; Tsuyuki RT; Ross CJD; Palijan A; Huynh L; Yordanova M; Crépeau-Hubert F; Wang S; Boyko D; Zappitelli M;
JAMA Netw Open; 2020 May; 3(5):e203639. PubMed ID: 32383745
[TBL] [Abstract][Full Text] [Related]
17. Kidney injury biomarkers 5 years after AKI due to pediatric cardiac surgery.
Greenberg JH; Devarajan P; Thiessen-Philbrook HR; Krawczeski C; Parikh CR; Zappitelli M;
Pediatr Nephrol; 2018 Jun; 33(6):1069-1077. PubMed ID: 29511889
[TBL] [Abstract][Full Text] [Related]
18. Hypertension in long-term childhood cancer survivors after treatment with potentially nephrotoxic therapy; DCCSS-LATER 2: Renal study.
Kooijmans ECM; van der Pal HJH; Pluijm SMF; Bresters D; van Dulmen-den Broeder E; van der Heiden-van der Loo M; van den Heuvel-Eibrink MM; Kremer LCM; Loonen JJ; Louwerens M; Neggers SJC; Pilon M; Ronckers C; Tissing WJE; de Vries ACH; Kaspers GJL; Bökenkamp A; Veening MA;
Eur J Cancer; 2022 Sep; 172():287-299. PubMed ID: 35810554
[TBL] [Abstract][Full Text] [Related]
19. Nephrotoxicity of cisplatin combination chemotherapy in thoracic malignancy patients with CKD risk factors.
Sato K; Watanabe S; Ohtsubo A; Shoji S; Ishikawa D; Tanaka T; Nozaki K; Kondo R; Okajima M; Miura S; Tanaka J; Sakagami T; Koya T; Kagamu H; Yoshizawa H; Narita I
BMC Cancer; 2016 Mar; 16():222. PubMed ID: 26979596
[TBL] [Abstract][Full Text] [Related]
20. Under-Recognition of Neonatal Acute Kidney Injury and Lack of Follow-Up.
Roy JP; Goldstein SL; Schuh MP
Am J Perinatol; 2022 Apr; 39(5):526-531. PubMed ID: 32971562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
